25 related articles for article (PubMed ID: 2570383)
1. [Anti H2 receptors and perforated peptic ulcer. Review of 442 cases].
Mastroianni V; Calgaro M; Manfredi S; Manzini R; Bevilacqua S
Minerva Chir; 1989 Nov; 44(21):2259-62. PubMed ID: 2576300
[TBL] [Abstract][Full Text] [Related]
2. Effect of H2 antagonists on outcome of simple closure for perforated duodenal ulcer.
Koh KB; Chang KW
Singapore Med J; 1992 Oct; 33(5):472-3. PubMed ID: 1360708
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological behavior of perforated peptic ulcer before and after the introduction of the antisecretory drug therapy. Our experience].
Sacco R; Giovanelli A; Giuliano L; Piazzalunga D; Poletti EM; Arrigoni F; Cassinelli GB
Minerva Chir; 1995 Oct; 50(10):871-8. PubMed ID: 8684634
[TBL] [Abstract][Full Text] [Related]
4. Simple closure and follow up H2 receptor antagonists for perforated peptic ulcer--immediate survival and symptomatic outcome.
Abbasakoor F; Attwood SE; McGrath JP; Stephens RB
Ir Med J; 1995; 88(6):207-10. PubMed ID: 8575920
[TBL] [Abstract][Full Text] [Related]
5. Emergency gastric ulcer complications in elderly. Factors affecting the morbidity and mortality in relation to therapeutic approaches.
Di Carlo I; Toro A; Sparatore F; Primo S; Barbagallo F; Di Blasi M
Minerva Chir; 2006 Aug; 61(4):325-32. PubMed ID: 17122765
[TBL] [Abstract][Full Text] [Related]
6. [Long-term evaluation of the treatment of perforated gastroduodenal ulcer using a median suture].
Uccheddu A; Murgia C; Dazzi C; Licheri S; Pia G; Cagetti M
Minerva Chir; 1989 Jun; 44(12):1637-41. PubMed ID: 2570383
[TBL] [Abstract][Full Text] [Related]
7. [Current theories on the treatment of peptic ulcer perforation].
Marzec B; Kowalczyk L
Wiad Lek; 1982 Dec; 35(22):1419-22. PubMed ID: 6762757
[No Abstract] [Full Text] [Related]
8. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
9. [Current status of therapy for gastroduodenal ulcer].
Aeberhard P; Lichtenhahn P; Villiger P
Schweiz Med Wochenschr; 1990 Apr; 120(14):467-75. PubMed ID: 1970909
[TBL] [Abstract][Full Text] [Related]
10. [Modern view of the pathogenesis and therapy of gastroduodenal peptic ulcer].
Vinci A; Alongi G; Falcone G; Santangelo G
Minerva Chir; 1990 Apr; 45(8):589-97. PubMed ID: 1975090
[TBL] [Abstract][Full Text] [Related]
11. The H2-receptor antagonist era in duodenal ulcer disease.
Marks IN
Yale J Biol Med; 1992; 65(6):639-48;discussion 689-92. PubMed ID: 1364125
[TBL] [Abstract][Full Text] [Related]
12. Drugs from emasculated hormones: the principle of syntopic antagonism.
Black J
Science; 1989 Aug; 245(4917):486-93. PubMed ID: 2569237
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
